Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.76 USD | +0.61% | +4.35% | -29.36% |
20/04 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
20/04 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.36% | 4.32B | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Goldman Sachs Starts Coverage on Immunovant With Buy Rating, $50 Price Target